Precision Syringe Company Profile

Background

Overview

Precision Syringe is a medical device company specializing in the development and manufacturing of advanced syringes designed to enhance injection precision, comfort, and safety. Founded in 2019 by Dr. Donny Suh, an ophthalmic surgeon, the company is headquartered in Omaha, Nebraska. The inception of Precision Syringe was driven by Dr. Suh's firsthand experience with the limitations of standard syringes during delicate retinal surgeries on premature infants. Collaborating with a team of physicians, students, and designers, Dr. Suh developed the Suh Precision Syringe, aiming to revolutionize injection technology.

Mission and Vision

The company's mission is to challenge the conventional perception of syringes as static, commoditized products. By focusing on intentional design and innovation, Precision Syringe seeks to provide healthcare practitioners with tools that improve patient outcomes through optimized delivery of injectable treatments. Their vision encompasses expanding the application of their technology across various medical specialties, including ophthalmology, aesthetics, and laboratory research.

Industry Significance

In the medical device industry, particularly within the syringe manufacturing sector, Precision Syringe stands out for its commitment to precision and user-centered design. The company's innovative approach addresses critical issues such as injection accuracy, patient comfort, and waste reduction, positioning it as a significant player in the market.

Key Strategic Focus

Core Objectives

Precision Syringe's strategic focus centers on:

• Innovation in Design: Developing syringes that offer unparalleled accuracy and comfort compared to conventional devices.

• User-Centered Approach: Ensuring that each product is designed with the end-user in mind, facilitating ease of use and effectiveness.

• Market Expansion: Broadening the application of their syringe technology across various medical fields to enhance patient care globally.

Areas of Specialization

The company specializes in:

• Ophthalmology: Providing precise injection tools for delicate eye surgeries.

• Aesthetics: Offering syringes designed for cosmetic procedures requiring high precision.

• Laboratory Research: Supplying syringes that meet the stringent demands of scientific experiments.

Key Technologies Utilized

Precision Syringe employs proprietary technologies in the design and manufacturing of their syringes, focusing on:

• Enhanced Accuracy Mechanisms: Innovative features that ensure precise dosage delivery.

• Ergonomic Designs: Syringes that are comfortable to use, reducing the risk of user fatigue and errors.

• Sustainable Materials: Utilizing materials that minimize waste and environmental impact.

Primary Markets Targeted

The company primarily targets:

• Healthcare Providers: Hospitals, clinics, and private practices seeking advanced injection tools.

• Medical Device Distributors: Partners interested in offering innovative syringe solutions.

• Research Institutions: Laboratories requiring high-precision syringes for experiments.

Financials and Funding

Funding History

Precision Syringe has secured funding through:

• Angel Investment: An announced angel investment round on January 10, 2024.

• Accelerator/Incubator Support: Completed participation in an accelerator/incubator program, indicating early-stage development and support.

Total Funds Raised

Specific details regarding the total funds raised are not publicly disclosed.

Notable Investors

The company has received backing from UNeTech, an accelerator/incubator, which has supported its growth and development.

Utilization of Capital

While exact allocations are not specified, the capital is likely utilized for:

• Product Development: Advancing the design and manufacturing of innovative syringes.

• Market Expansion: Increasing distribution and outreach to new markets.

• Operational Scaling: Enhancing production capabilities to meet growing demand.

Pipeline Development

Key Pipeline Candidates

As a privately held company, specific details about pipeline candidates are not publicly available.

Stages of Development

The company is in the early stages of product development, focusing on refining its syringe designs and preparing for broader market introduction.

Target Conditions

The syringes are designed for use in:

• Ophthalmic Surgeries: Particularly delicate eye procedures.

• Aesthetic Treatments: Cosmetic injections requiring high precision.

• Laboratory Research: Experiments necessitating accurate liquid handling.

Anticipated Milestones

The company aims to achieve:

• Product Launches: Introducing syringes to the market in the near future.

• Regulatory Approvals: Obtaining necessary certifications for medical devices.

• Market Penetration: Establishing a presence in key healthcare and research sectors.

Technological Platform and Innovation

Proprietary Technologies

Precision Syringe's proprietary technologies include:

• Enhanced Accuracy Mechanisms: Innovative features that ensure precise dosage delivery.

• Ergonomic Designs: Syringes that are comfortable to use, reducing the risk of user fatigue and errors.

• Sustainable Materials: Utilizing materials that minimize waste and environmental impact.

Significant Scientific Methods

The company employs:

• User-Centered Design: Focusing on the needs and feedback of healthcare practitioners to inform product development.

• Rigorous Validation: Ensuring that products meet higher standards through thorough testing and quality control.

AI-Driven Capabilities

While specific AI-driven capabilities are not detailed, the company's commitment to innovation suggests potential integration of advanced technologies in future product developments.

Leadership Team

Adrian Blake

• Position: Founder & Chief Executive Officer

• Professional Background: Management consultant, entertainment executive, and musician.

• Contributions: Coordinates production, approval processes, and global partnerships to bring Precision Syringe's products to market.

Dr. Donny Suh

• Position: Chief Medical Officer

• Professional Background: Ophthalmic surgeon with experience in retinal surgeries.

• Contributions: Developed the Suh Precision Syringe, addressing the need for more precise injection tools in medical procedures.

Competitor Profile

Market Insights and Dynamics

The global syringe market is projected to grow from $2.47 billion in 2025 to $3.64 billion by 2031, with a compound annual growth rate (CAGR) of 6.71%.

Competitor Analysis

Key competitors in the syringe market include:

• Becton, Dickinson and Company (BD): Dominates the global syringe market with a diverse portfolio, including safety syringes and prefilled formats.

• Terumo Corporation: Leads in prefilled and thin-wall syringe technologies, emphasizing precision engineering.

• Nipro Corporation: Secures mid-market share through cost-efficient mass production of hypodermic syringes.

• B. Braun Melsungen AG: Offers a broad range of infusion and syringe sets with German quality certifications.

• Cardinal Health: Pairs private-label syringes with an expansive U.S. distribution network.

• Baxter International: Focusing on specialty oncology and critical-care syringes leveraging compound-drug expertise.

• Gerresheimer AG: Excels in glass prefillable syringes and drug-device combination offerings.

• Smiths Medical: Blends insulin delivery systems with connected-care software.

• Hindustan Syringes & Medical Devices: Asia’s largest auto-disable syringe producer with cost-optimized high-volume lines.

• Revolutions Medical Corp.: Pioneers spring-loaded